Karuna Therapeutics
(NASDAQ) KRTX
Karuna Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$654.00K
Net Income (TTM)
$422.19M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
KRTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Karuna Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
339
CEO
William J. Meury
Website
www.karunatx.comHeadquarters
Boston, MA 02110, US
KRTX Financials
Key Financial Metrics (TTM)
Gross Margin
-2%
Operating Margin
-757%
Net Income Margin
-663%
Return on Equity
-36%
Return on Capital
-39%
Return on Assets
-32%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$1.05M
Operating Income
$494.78M
EBITDA
$493.08M
Operating Cash Flow
$385.82M
Capital Expenditure
$2.92M
Free Cash Flow
$388.74M
Cash & ST Invst.
$1.26B
Total Debt
$16.69M
Karuna Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$447.00K
-109.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
339
N/A
Net Income
$113.82M
-49.4%
EBITDA
$101.22M
-54.6%
Quarterly Fundamentals
Net Cash
$1.25B
+11.4%
Accounts Receivable
$4.90M
+8496.5%
Inventory
$32.83M
N/A
Long Term Debt
$13.85M
+354.5%
Short Term Debt
$2.84M
+24.6%
Return on Assets
-32.46%
N/A
Return on Invested Capital
-39.02%
N/A
Free Cash Flow
$111.86M
-41.5%
Operating Cash Flow
$111.06M
-41.0%